Mechanism studies have confirmed that A2AR activation attenuates progression of experimental arthritis by inhibiting TNF-α [20] and IL-1β production [21], both of which are the key pro-inflammatory cytokines in the pathogenesis of inflammation flare. This evidence concerns the gene IL1B and Arthritis.